Why has HireRight's drug screening service utilization decreased by 20% among healthcare clients in the past 60 days?

Introduction

The recent 20% decrease in HireRight's drug screening service utilization among healthcare clients over the past 60 days is a significant concern that requires immediate attention and a thorough root cause analysis. To address this issue, I'll employ a systematic approach to identify, validate, and resolve the underlying factors contributing to this decline. My analysis will cover multiple aspects, from data gathering and hypothesis formation to solution development and implementation.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a seasonal component. Has this 60-day period coincided with any typical hiring slowdowns in the healthcare industry?

Why it matters: Seasonal trends could explain the decrease and inform our solution approach. Expected answer: No significant seasonal trends in healthcare hiring during this period. Impact on approach: If seasonal, we'd focus on strategies to offset cyclical declines.

• Considering the specificity of the decrease, I'm wondering about recent changes. Have there been any updates to HireRight's drug screening service or pricing in the last 90 days?

Why it matters: Recent changes could directly impact utilization rates. Expected answer: No major changes to the service or pricing structure. Impact on approach: If changes occurred, we'd investigate their specific effects on healthcare clients.

• Given the healthcare focus, I'm curious about regulatory shifts. Have there been any recent changes in healthcare industry regulations regarding drug screening?

Why it matters: Regulatory changes could significantly impact drug screening requirements. Expected answer: No major regulatory changes in the healthcare sector. Impact on approach: If regulatory changes occurred, we'd need to adapt our service to new requirements.

• Noticing the specific percentage, I'm thinking about measurement accuracy. Has there been any change in how we measure or report drug screening service utilization?

Why it matters: Ensures we're addressing a real issue, not a reporting anomaly. Expected answer: No changes in measurement or reporting methods. Impact on approach: If measurement changes occurred, we'd need to reassess the actual decline.